A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers

NCT00741026 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Insulin Resistance
Diabetes Mellitus

Interventions

DRUG: Olanzapine 10 mg po qhs for 3 days
DRUG: Placebo

Sponsor

Milton S. Hershey Medical Center

Collaborators

[object Object]